CD34 and metastatic neoplasm: No statistically significant association was found between CD34-indexTN and age (p = 0.543), sex (p = 0.748), treatment group (p = 0.848), IMDC prognostic group (p = 0.152), target lesion volume (p = 0.434), or synchronous versus. metachronous metastatic disease (p = 0.378).